New Milford, CT, United States of America

Said Saim

USPTO Granted Patents = 24 


Average Co-Inventor Count = 3.3

ph-index = 11

Forward Citations = 725(Granted Patents)


Location History:

  • Lawrence, KS (US) (1997 - 1999)
  • New Milford, CT (US) (1998 - 2020)
  • Wrentham, MA (US) (2017 - 2020)

Company Filing History:


Years Active: 1997-2020

Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: **The Innovations of Said Saim: Pioneering Solutions in Pharmaceutical Compositions**

Introduction

Said Saim, a talented inventor based in New Milford, CT, holds an impressive portfolio of 24 patents that reflect his dedication to developing innovative solutions in the pharmaceutical industry. His work primarily focuses on enhancing drug formulations to combat misuse while ensuring effective therapeutic delivery.

Latest Patents

Saim's latest patents include groundbreaking advancements such as tamper-resistant pharmaceutical compositions of opioids and other drugs. These formulations are designed to reduce the likelihood of improper administration, particularly for highly addictive substances like opioids. The innovative tamper-resistant compositions are engineered to delay drug release even if the physical integrity of the formulation is compromised. This ensures that if the material is manipulated—whether by chopping, crushing, or dissolving—it retains its effectiveness when taken as directed.

Another significant contribution from Saim is the development of a process for making stable abuse-deterrent oral formulations. This disclosure outlines techniques to create cured pharmaceutical compositions aimed at minimizing the potential for drug abuse. By enhancing the dissolution stability of these formulations, Saim has significantly improved methods for pain treatment while prioritizing safety.

Career Highlights

Said Saim has garnered extensive experience working with major players in the pharmaceutical industry, including Boehringer Ingelheim Pharmaceuticals, Inc. and Collegium Pharmaceutical, Inc. His time at these companies has allowed him to collaborate on various projects, further contributing to the advancement of pharmaceutical innovations.

Collaborations

Throughout his career, Saim has had the privilege of collaborating with esteemed colleagues such as Stephen T. Horhota and Alison B. Fleming. Together, they have worked on innovative projects that aim to redefine safety and efficacy in drug administration.

Conclusion

Said Saim's contributions to the pharmaceutical industry demonstrate his commitment to innovation and safety. Through his numerous patents and collaborations, he continues to play a vital role in developing solutions that address the challenges of drug misuse and enhance patient care. His work not only pushes the boundaries of pharmaceutical science but also holds the potential to significantly impact public health and safety.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…